Eesti -
eesti -
Ravimiamet
lebsanan salv
norameda uab - takroliimus - salv - 1mg 1g 30g 1tk; 1mg 1g 10g 1tk
Eesti -
eesti -
Ravimiamet
betnovate cream kreem
glaxosmithkline (ireland) limited - beetametasoon - kreem - 1mg 1g 15g 1tk
Eesti -
eesti -
Ravimiamet
dermovate ointment salv
glaxosmithkline (ireland) limited - klobetasool - salv - 500mcg 1g 25g 1tk
Eesti -
eesti -
Ravimiamet
montelukast accord närimistablett
accord healthcare b.v. - montelukast - närimistablett - 4mg 30tk; 4mg 100tk; 4mg 28tk; 4mg 20tk; 4mg 50tk; 4mg 56tk; 4mg 200tk; 4mg 14tk; 4mg 7tk; 4mg 10tk
Eesti -
eesti -
Ravimiamet
betnovate ointment salv
glaxo wellcome uk limited trading as glaxo wellcome operations - beetametasoon - salv - 1mg 1g 15g 1tk
Eesti -
eesti -
Ravimiamet
movalis tablett
boehringer ingelheim international gmbh - meloksikaam - tablett - 7,5mg 20tk
Eesti -
eesti -
Ravimiamet
dermovate nahalahus
glaxosmithkline (ireland) limited - klobetasool - nahalahus - 500mcg 1ml 25ml 1tk
Eesti -
eesti -
Ravimiamet
movalis tablett
boehringer ingelheim international gmbh - meloksikaam - tablett - 15mg 20tk
Euroopa Liit -
eesti -
EMA (European Medicines Agency)
palforzia
aimmune therapeutics ireland limited - defatted powder of arachis hypogaea l., semen (peanuts) - peanut hypersensitivity - allergens - palforzia is indicated for the treatment of patients aged 4 to 17 years with a confirmed diagnosis of peanut allergy. palforzia may be continued in patients 18 years of age and older. palforzia should be used in conjunction with a peanut-avoidant diet.
Euroopa Liit -
eesti -
EMA (European Medicines Agency)
vumerity
biogen netherlands b.v. - diroximel fumarate (biib098) - sclerosis multiplex, relapsing-remitting - immunosupressandid - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).